作者: Charles Gluchowski , T. G. Murali Dhar , Wai C. Wong , Yoon T. Jeon
DOI:
关键词:
摘要: This invention is directed to novel imidazole and imidazoline derivatives which are selective agonists for cloned human α2 adrenergic receptors. also related the use of these compounds treatment any disease where modulation receptors may be useful. The further provides a pharmaceutical composition comprising therapeutically effective amount above-defined pharmaceutically acceptable carrier.